MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    A human tissue engineered nigrostriatal system as a testbed for understanding PD pathophysiology and therapeutic development

    D. Chouhan, K. Browne, R. Patel, S. Karandikar, F. Laimo, D. Cullen, J. Duda (Philadelphia, USA)

    Objective: The objective of these studies is to develop a tissue engineered nigrostriatal system involving human dopaminergic and striatal cells to recapitulate many of the…
  • 2023 International Congress

    Parkinson’s Disease Hospital Optimization Project

    B. Valdovinos, K. Amodeo, E. Kanouse, A. Chesire, J. Lowell, M. Braun, N. Chunga, D. Ruebeck, A. Macikowski, V. Basic, M. Deweese, E. Hufziger, J. Hayes, A. Skuse, I. Richard (Rochester, USA)

    Objective: To describe The Parkinson’s Disease Hospital Optimization Project (PD-HOP) that we established to optimize inpatient care and improve the hospital experience and outcomes for…
  • 2023 International Congress

    Long-term effectiveness of adjuvant treatment with catechol-o-methyltransferase or monoamine oxidase B inhibitors compared with dopamine agonists in Parkinson’s disease uncontrolled by levodopa: final results of the PD MED LATER randomized clinical trial

    C. Clarke, C. Rick, S. Patel, R. Wooley, N. Rowland, J. Futterer, R. Ottridge, C. Jenkinson, R. Gray (Birmingham, United Kingdom)

    Objective: PD MED LATER is a large, pragmatic trial aiming to determine which class of drug when added to levodopa provides the most effective control…
  • 2023 International Congress

    Detection of Levodopa induced Dyskinesia based on spectral features from subthalamic-LFP and sensorimotor-ECoG

    J. Habets, R. Lofredi, J. Busch, V. Mathiopoulou, J. Roediger, R. Koehler, J. Vanhoecke, P. Krause, K. Faust, GH. Schneider, WJ. Neumann, A. Kühn (Berlin, Germany)

    Objective: To detect the presence of Levodopa induced Dyskinesia (LID) in Parkinson’s disease (PD) patients based on spectral characteristics from invasive cortico-subthalamic recordings using machine…
  • 2023 International Congress

    Anodal Transcranial Direct Current Stimulation (tDCS) on sensorimotor cortex in patients with early-onset Parkinson’s Disease: a Pilot Study.

    C. Simonetta, J. Bissacco, M. Conti, V. Ferrari, M. Pierantozzi, C. Salimei, A. Stefani, NB. Mercuri, T. Schirinzi (Roma, Italy)

    Objective: To evaluate the clinical effects of anodal Transcranial Direct Current Stimulation (tDCS) application on sensorimotor cortex in a group of early-onset Parkinson’s Disease patients.…
  • 2023 International Congress

    Exome sequencing of 584 Chinese proband with brain calcification

    ZR. Lin (Hangzhou, China)

    Objective: The aim of this study is to evaluate the diagnostic value of whole exome sequencing in Chinese patients with brain calcification, and to provide exome sequencing-based insights into the genetic…
  • 2023 International Congress

    Effectiveness of use of Pictographs on Levodopa packaging to ensure awareness of Levodopa/Carbidopa spacing with meals in patients of Idiopathic Parkinson’s disease.

    M. Matta, N. Sawal (Chandigarh, India)

    Objective: Food interferes with gastrointestinal absorption of levodopa which requires spacing with meals. This study aimed to evaluate the effect pictographs on Levodopa packaging Fig 1 on increasing patient…
  • 2023 International Congress

    Addition contact with 10 Hz stimulation in the STN may improve stimulation-induced cognitive disturbances

    A. Boogers, M. Cohn, M. Bernstein, A. Fasano (Toronto, Canada)

    Objective: This case report demonstrates improvement of cognition by adding low-frequency stimulation in the ventral subthalamic nucleus (STN). Background: Deep brain stimulation (DBS) targeting the…
  • 2023 International Congress

    Observations on 5 Parkinson’s patients taking Mucuna pruriens as natural source of levodopa

    S. Elsas (Arlesheim, Switzerland)

    Objective: To explore potential benefits and tolerability of extracts from Mucuna pruriens for dopaminergic treatment of Parkinson’s patients. Background: Capsules containing freeze-dried, aqueous extract from…
  • 2023 International Congress

    Informing people with Parkinson’s disease of their gene variant status: PD GENEration, a North American observational and registry study

    L. Cook, J. Verbrugge, T. Schwantes-An, T. Foroud, A. Hall, K. Marder, I. Mata, N. Mencacci, M. Nance, M. Schwarzschild, T. Simuni, A-M. Wills, S. Rao, K. Ghosh Galvelis, A. Naito, J. Beck, R. Alcalay (Indianapolis, USA)

    Objective: To describe genetic testing results of major genes for Parkinson’s disease (PD) in a North American cohort as part of PD GENEration Background: Although…
  • « Previous Page
  • 1
  • …
  • 299
  • 300
  • 301
  • 302
  • 303
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley